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The exposure of the plasma membrane calcium pump
(PMCA) to the surrounding phospholipids was assessed by
measuring the incorporation of the photoactivatable phosphati-
dylcholine analog [125I]TID-PC/16 to the protein. In the pres-
enceofCa2both calmodulin (CaM) andphosphatidic acid (PA)
greatly decreased the incorporation of [125I]TID-PC/16 to
PMCA. Proteolysis of PMCA with V8 protease results in three
main fragments: N, which includes transmembrane segments
M1 and M2; M, which includes M3 and M4; and C, which
includes M5 to M10. CaM decreased the level of incorporation
of [125I]TID-PC/16 to fragmentsMandC,whereas phosphatidic
acid decreased the incorporation of [125I]TID-PC/16 to frag-
ments N and M. This suggests that the conformational changes
induced by binding of CaM or PA extend to the adjacent trans-
membrane domains. Interestingly, this result also denotes dif-
ferences between the active conformations produced by CaM
and PA. To verify this point, we measured resonance energy
transfer betweenPMCA labeledwith eosin isothiocyanate at the
ATP-binding site and the phospholipid RhoPE included in
PMCA micelles. CaM decreased the efficiency of the energy
transfer between these two probes, whereas PA did not. This
result indicates that activation by CaM increases the distance
between the ATP-binding site and the membrane, but PA does
not affect this distance. Our results disclose main differences
betweenPMCAconformations induced byCaMorPAand show
that those differences involve transmembrane regions.
The plasma membrane calcium pump (PMCA)3 is an inte-
gral membrane protein that actively removes calcium from the
cytoplasm of eukaryotic cells. Its ATPase activity is enhanced
by several modulators among which calmodulin (CaM) and
acidic phospholipids appear to be themost effective. CaMbinds
to the C-terminal end of PMCA (1–3), a domain that displays a
high content of basic amino acid residues. Cross-linking exper-
iments revealed that the N-terminal half of this sequence inter-
acts with a region located just upstream transmembrane
segment M3 (Cys537–Thr544), whereas the C-terminal part
interacts with another one located downstream transmem-
brane segmentM4 (Ile206–Val271) (4, 5). This interaction causes
the autoinhibition of the enzyme activity. Upon CaM binding,
the interaction is disrupted, which results in an enhanced
ATPase activity. Acidic phospholipids exert their effect on
PMCA activity by accelerating the dephosphorylation step of
the enzyme reaction cycle (6). Two binding sites for acidic
phospholipids have been described within PMCA (7, 8). The
one mainly responsible for the activation effect is located near
transmembrane segmentM3 (9). Binding of acidic phospholip-
ids to this site also appears to relieve autoinhibition because
deletion of a segment comprising amino acids 296–349 renders
a high calcium affinity enzyme that is almost non-responsive to
further activation by acidic phospolipids (10). Interestingly, this
binding site partially overlaps the C-terminal receptor region.
For instance, synthetic peptides, including amino acids 339–
363 or 348–370, i.e. acidic phospholipids binding site, were
shown to effectively bind CaM and the CaM binding region as
well. Acidic phospholipids bind to a second site located in the
C-terminal domain of PMCA (7, 8). The contribution of this
binding to the activation of the enzyme has been explored lately
using isoform 2 of PMCA (11) but remains unclear for
h4PMCA. The conformation adopted by PMCA upon activa-
tion has been recently studied by different techniques. Activa-
tion by CaM or acidic phospholipids increases the distance
between N- and C-terminal domains of PMCA (12). Besides,
the transmembrane arrangement of CaM-bound PMCA was
shown to bemore compact than that in the presence of calcium
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but absence of CaM (13). The aim of this work was to gain
further insight into the structural changes elicited by CaM and
phosphatidic acid (PA) on PMCA transmembrane region. To
this end, we used a photolabeling approach previously shown to
accurately sense differential exposure of transmembrane
domains to surrounding phospholipids resulting from different
conformations adopted by the protein (13). Our results show
that CaM and PA behave independently regarding their effects
on enzyme activity and transmembrane conformation. More-
over, activation elicited by CaM involves structural rearrange-
ments within PMCA transmembrane domain markedly differ-
ent from those taking place upon activation by acidic
phospholipids.
EXPERIMENTAL PROCEDURES
Reagents—All chemicals used in this work were of analytical
grade and purchased mostly from Sigma. Recently drawn
human blood for the isolation of PMCAwas obtained from the
Hematology Section of the Hospital de Clínicas General San
Martín and from Fundacion Fundosol (Argentina). Blood
donation in Argentina is voluntary, and therefore the donor
provides informed consent for the donation of blood and for the
subsequent legitimate use of the blood by the transfusion
service.
Purification of PMCA from Human Erythrocytes—PMCA
was isolated from calmodulin-depleted erythrocyte mem-
branes by the calmodulin affinity chromatography procedure
(14) asmodified by Filomatori and Rega (6). Protein concentra-
tion after purification was10 g/ml. No phospholipids were
added at any step along the purification procedure. By mea-
suring inorganic phosphate (see “Phospholipid Quantification”),
we estimated that1 mol of natural phospholipids per mol of
PMCA is present in the purified enzyme. The purification pro-
cedure described preserves transport activity andmaintains the
kinetic properties and regulatory characteristics of the enzyme
in its native milieu (6).
Measurement of Ca2-ATPase Activity—Ca2-ATPase
activity wasmeasured at 37 °C as the initial velocity of release of
Pi from ATP as described previously (6). The incubation
medium contained 80 MDMPC, 120MC12E10, 120 mMKCl,
30 mM MOPS-K (pH 7.4), 3.75 mM MgCl2, 1 mM EGTA, and
enough CaCl2 to give the desired final free [Ca2] as specified
for each experiment. When necessary, calmodulin and/or 1,2-
distearoyl-sn-glycero-3-phosphate (PA) were added, and their
concentration is indicated in each figure. Release of Pi was
estimated according to the procedure of Fiske and Subbarow
(15). Measurements were performed in a Jasco V-630 Bio
spectrophotometer.
Preparation of [125I]TID-PC/16—TTD-PC/16 (tin precur-
sor) was a kind gift of Dr. J. Brunner (ETH Zentrum, Zurich,
Switzerland). [125I]TID-PC/16 was prepared by radioiodina-
tion of its tin precursor according to Weber and Brunner (16).
Phospholipid Quantification—Phospholipid concentration
was measured according to Chen et al. (17).
Labeling Procedure—A dried film of the photoactivatable
reagent was suspended in PC/C12E10 or PA/C12E10 mixed
micelles containing 10 g/ml of the membrane protein. The
samples were incubated for 20 min at 25 °C before being
irradiated for 15 min with light from a filtered UV source
(  360 nm).
Radioactivity and Protein Determination—Electrophoresis
was performed according to the Tris-Tricine SDS-PAGE
method (18). Isocratic gels (7.5% T and 1% C and 1-mm thick)
were used for undigested PMCA.When the protocols required
isolation of proteolytic fragments, gradient gels (4–20%) were
used. Polypeptides were stained with Coomassie Blue R; the
isolated bands were excised from the gel, and the incorporation
of radioactivity was directly measured on a gamma counter.
The amount of protein was quantified by eluting each stained
band, as described previously (19), including bovine serum
albumin in each gel as a standard for protein quantification.
Specific incorporation was calculated as the ratio between
measured radioactivity and amount of protein determined for
each band.
V8 Protease Proteolysis of PMCA—After photolysis, the
labeled samples were dialyzed against 50 mM Tris-H3PO4 (pH
7.2) and then supplemented with 0.8% SDS and digested with
V8 protease (200 ng per ml) at 25 °C. The reaction was stopped
after 3 h by the addition of TCA up to a final concentration of
10%. The identity of the fragments was confirmed by immuno-
blotting and protein N-terminal sequencing as described pre-
viously (20–22).
Analysis of SERCA Structure and Accessible Surface Area—
The crystal structures used for comparison were as follows:
Protein Data Bank codes 1SU4 (23) and 2EAR (24).
The transmembrane regions were taken as explicitly defined
in Uniprot for sarcoplasmic/endoplasmic reticulum calcium
ATPase 2, accession no. P20647. The accessible surface area
(ASA) of the transmembrane helices was calculated with Mol-
Mol (25, 26) with a solvent radio of 1.4 Å. Superposition of
crystal structures was performed with POSA (27).
Spectroscopic Measurements—The fluorescence measure-
ments were made in a quartz cell of 3  3 mm using an SLM-
spectrofluorometer AMINCOBOWMAN Series 2 (Spectronic
Instrument, Inc., Rochester, NY). The excitation and emission
bandwidths were set at 4 nm.
Labeling with Isothiocyanate 5-Eosin (EITC)—The calcium
pump was labeled with isothiocyanate 5-eosin as described
previously (28). In these conditions, only Lys495 becomes
labeled (28, 29). The stoichiometry of labeling (0.96  0.6 mol
of EITC per mol of ATPase) was determined by measuring the
light absorption in the presence of 1% SDS, 0.1 M NaOH, con-
sidering a molar extinction coefficient of 83,000 M1/1 cm1 at
522 nm for EITC-PMCA (30).
After labeling with EITC, the enzyme completely lost its
Ca2-ATPase activity. The inhibition of the enzyme by EITC is
a consequence of the selective binding of this probe to lysine
495 in hPMCA4b isoform residue located near theATPbinding
site (30). These authors observed that the enzyme is not able to
bind ATP after chemical modification with either of these
probes. In addition, the enzyme properties that do not depend
on ATP binding are conserved after the specific labeling. Par-
ticularly, the labeled enzymes preserve the ability to bind cal-
modulin in a Ca2-dependent mode, exhibit calmodulin-de-
pendent phosphatase activity (31), and dimerize (32). The
labeled protein has a single fluorescence emissionmaximum of
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548 nm. The maximum excitation at 532 nm was observed
according to previous reports (33).
RhoPE-containing Micelles—A lyophilized powder of lissa-
mine rhodamine-B1,2-sn-glycerides dihexadecanoyl-3-phos-
phatidylethanolamine (RhoPE) was resuspended in 500 l of
CH3OH-CHCL3 (2:1), aliquoted into equal parts, and carried to
dryness. The films obtained were stored at 20 °C, protected
from light. In the elution buffer of PMCA, the probe shows
maximum excitation at 573 nm and a single fluorescence emis-
sion peak at 588 nm. The concentration used was always 2%
mol/mol. Under these conditions no self-quenching effects are
observed (34). When increasing concentrations of PC, PE, or
PA were needed, these phospholipids were sonicated until the
total disappearance of turbidity. They were added to EITC-
PMCA reconstituted in micelles of C12E10 containing RhoPE
and incubated 20 min prior to the florescence measurement.
The efficiency of fluorescence energy transfer (E) was mea-
sured from the decrease on the donor fluorescence caused by the
presence of the acceptor according to the following equation
(35): E 1 F/F0, where F and F0 are the EITC-PMCA emis-
sion intensity in the presence or the absence of RhoPE,
respectively.
Analysis of Data—All measurements were performed in
duplicate to quintuplicate. SDS gels presented under “Results”
were chosen as representative of at least three independent
experiments.
RESULTS
Effect of CaM and PA on PMCA Enzymatic Activity—Ca2-
ATPase activity of PMCA was measured in the presence of
increasing concentrations of CaM (Fig. 1A). A hyperbolic func-
tion (Equation 1) was fitted to the experimental data, and the
best fit value parameter obtained forKCaMwas 10.7 1.2 nM in
good agreement with previously reported values obtained from
PMCA activity measurements (36, 37).
Y 
A	CaM

KCaM 	CaM

(Eq. 1)
This parameter remained unchanged in the presence of 60 M
PA (9.4  0.6 nM). However, the best fit parameter value
obtained forA, i.e. enzyme activation over a basal activity in the
absence of modulators, increased from 136  4.4% in the
absence of PA to 253.1  17.2% in the presence of this modu-
lator. ATPase activity was then assessed using increasing PA
concentrations (Fig. 1B). Equation 1 was fitted to the experi-
mental points, but now the variable was the concentration of
PA instead of the concentration of CaM. Accordingly, KCaM of
Equation 1 is replaced by KPA. The best fit parameter value for
KPA thus obtained was 21.8 3.8M. As before, this parameter
remained constant in the presence of 50 nM CaM (21.7  3.2
M),whereasA increased from127.1 4.1 to 229 11.6. These
results suggest that CaM and PA binding sites responsible for
PMCA activation are independent.
Effect of CaM and PA on [125I]TID-PC/16 Incorporation to
PMCA—[125I]TID-PC/16 is a photoactivatable reagent that has
been shown previously to behave as PC regarding protein-lipid
interactions (38, 39). It is thus possible to assess lipid exposure
of transmembrane protein regions by quantifying the amount
of reagent that becomes covalently attached to the protein upon
photolysis (40). [125I]TID-PC/16 is used as a probe, i.e. its con-
centration in the labeling medium is negligible. As a PC analog,
it is not expected to preferentially bind any sites within PMCA.
Its incorporation to the protein is therefore an accurate report
of the overall conformational changes occurring upon activa-
tion by CaM or PA. These latter compounds were used at suit-
able concentrations to achieve maximal activity of the pump.
We first wished to determine the extent of [125I]TID-PC/16
labeling of the PMCA in itsmajor knownconformational states.
The E2 state is attained by incubating PMCA in the absence of
Ca2 (1 mM EGTA). The incorporation of [125I]TID-PC/16 in
this condition was considered as the control and was set as
100%. The other two conformers are E1I and E1A. E1I is
obtained by incubating the enzyme in the presence of Ca2 and
binds the maximum amount of [125I]TID-PC/16 (155% at opti-
mal concentration of Ca2). E1A is a conformation attainable in
the presence of Ca2 and CaM, which binds 75% of the control.
These data are similar as those reported earlier (13) and illus-
trate the sensitivity of [125I]TID-PC/16 incorporation to the
different PMCA conformations. To estimate the level of expo-
sure of activated PMCA to surrounding phospholipids, we
labeled the enzyme in the presence of CaM, PA, or CaMand PA
(Fig. 2). A similar behavior to that observed with CaM was
observed with PA, i.e. exposure of the transmembrane region
FIGURE 1. Dependence of Ca2-ATPase activation as a function of [CaM]
and [PA].A, functionof [CaM] in the absenceor presenceof 60MPA.B, func-
tion of [PA] in the absence or presence of 50 nM CaM. The [Ca2]free was 3M.
ATPase activity in the absence of activators was taken as 100%. Values
reported are mean S.E. of three independent experiments.
FIGURE 2. Relative specific incorporation of [125I]TID-PC/16 to PMCA
under different conditions. The specific incorporation in the presence of 1
mM EGTA was taken as 100% (EGTA). Ca2, 100 M Ca2; CaM, 100 M Ca2
and 200 nM CaM. PA, 100 M Ca2 and 60 M PA. CaMPA, 100 M Ca2 200
nM CaM and 60M PA (E1A). Values reported aremean S.E. of five indepen-
dent experiments.
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also decreases in the presence of this activator. However, the
effect observed with PA is less pronounced than that observed
withCaM.Moreover, whenCaM is already bound to PMCA, no
further changes in the average transmembrane exposure to lip-
ids occur upon PA binding. These results suggest that the
degree of compaction attained by the transmembrane region is
maximal in the presence of CaM.
Quantitative Analysis of CaM and PA Binding Processes—
According to our results, activation triggers a conformational
change in PMCA transmembrane domain, which results in less
incorporation of [125I]TID-PC/16. To further explore this
effect, we performed a photolabeling experiment in which
increasing amounts of CaM were added to the incubation
medium in the presence or absence of PA (Fig. 3A). In this
experiment, we titrated the amount of [125I]TID-PC/16 that
binds to PMCA as it shifts from the E1I to the E1A conformer as
we have described previously (41).
Equation 2 was fitted to the experimental data. This empiri-
cally derived equation characterizes the effect of CaM on the
amount of [125I]TID-PC/16 bound to PMCA.
PCB PCmin
PC0 PCmin
1 	CaM
KD	CaM

n (Eq. 2)
The PCB parameter represents the specific incorporation of
[125I]TID-PC/16 to PMCA at a given concentration of CaM,
PC0 is the specific incorporation in the absence of CaM, PCmin
is the minimal level of specific incorporation, n is the Hill coef-
ficient, and KD[CaM] the concentration of CaM at which half-
maximal incorporation is attained. The best fit value parameter
obtained for PC0 in the absence of PA was 154.8  2.6%,
whereas those obtained for PCmin, n, and KD[CaM] were 71.9
1.8%, 1.9  0.4, and 9.6  0.8 nM, respectively. The values
obtained for PC0 and PCmin illustrate the previously described
compaction effect exerted by CaM on PMCA transmembrane
region. In the presence of 60 M PA, the value parameters
obtained were PC0  91.4  1.4%, PCmin  74.7  0.9, n 
2.3 0.4, and KD[CaM] 8.5 1.2. The value obtained for PC0
under this condition illustrates the more compact conforma-
tion adopted by PMCA transmembrane region in the presence
of PA and that obtained for PCmin shows that CaM exerts an
additional effect. The degree of compaction achieved is indis-
tinguishable from that attained in the absence of PA. The value
obtained forKD[CaM] in the absence of PA is in good agreement
with the value we calculated for KCaM from Fig. 1, with the
reported affinity constant for CaM obtained by enzyme activity
measurements (36, 37), and with that obtained by fluorescence
polarization (42). These results show that the values for the
dissociation constant of CaM calculated from the change in
[125I]TID-PC/16 incorporation and from enzyme activation are
very similar, validating the use of [125I]TID-PC/16 incorpora-
tion to follow the conformational shift from E1I to E1A. This
parameter remained unchanged in the presence of 60 M PA,
which suggests that the CaM binding site responsible for the
observed conformational effects does not overlap with the
acidic phospholipid binding site.
Fig. 3B shows the PA-dependent incorporation of [125I]TID-
PC/16 in the absence or presence of 50 nMCaM. Equation 2was
fitted to the experimental data, but now the variable was the
concentration of PA instead of the concentration of CaM.
Accordingly, KD[CaM] of Equation 2 is replaced by KD[PA], and
PC0 reflects the initial amount of [125I]TIDPC/16 bound in the
absence of PA. In this case, the best fit value parameters
obtained for PC0, PCmín, n, and KD[PA] were 153.0  2.2%,
89.8  2.0%, 1.7  0.24, and 16.5  2.3 M, respectively. As
before, the values obtained for PC0 and PCmin illustrate the
effect exerted by PA on the degree of compaction of PMCA
transmembrane region. The value obtained for KD[PA] is also in
good agreement with that obtained for KPA using enzymatic
activity measurements (see above). By contrast, in the presence
of 50 nMCaM, no changes in [125I]TID-PC/16 specific incorpo-
ration to PMCAwere observed upon increasing concentrations
of PA (Fig. 3B). The average value obtainedunder this condition
was 75.2  3.4, which is indistinguishable from that obtained
for PCmin upon increasing [CaM] in the presence of PA (76.9
1.8%). This result suggests that regarding its transmembrane
conformation, CaM-bound PMCA becomes insensitive to
binding of PA and further points to nonoverlapping binding
sites of these two enzyme activity modulators.
Differential Exposure of PMCA Hydrophobic Domains—It is
possible to obtain a highly reproducible proteolysis pattern of
PMCA by using V8 protease under controlled conditions
(Scheme 1). Each of the resulting fragments includes two (frag-
ments N andM) or six (fragment C) transmembrane segments.
Therefore, the combined strategy of photolabeling followed by
controlled digestion of PMCAallowed us to analyze the specific
incorporation of [125I]TID-PC/16 to three different hydro-
phobic domains of the transmembrane region (43). We
assessed the amount of [125I]TID-PC/16 covalently attached to
each of the proteolitic fragments after photolabeling the
enzyme in the presence of EGTA, Ca2, Ca2 and CaM, Ca2
and PA or Ca2, CaM, and PA. Specific incorporation to each
fragment in the presence of EGTA was considered as the con-
trol and was set as 100%. Specific incorporation of the reagent
to fragment N, M, and C was higher in the presence of Ca2
than in the absence of the ion (Fig. 4A). On the other hand,
specific incorporation to any of the fragments was decreased
markedly in the presence of either CaM or PA (Fig. 4, B and C),
FIGURE 3. Incorporation of [125I]TID-PC/16 to PMCA upon activation by
calmodulin or phosphatidic acid activation. A, purified PMCA was photo-
labeled in the presence of 100MCa2 and increasingCaMconcentrations in
the presence or absence of 60 M PA. B, purified PMCA was photolabeled in
the presence of 100 M Ca2 and increasing PA concentrations in the pres-
ence or absence of 100 nM CaM. Values reported are mean  S.E. of three
independent experiments.
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mimicking the results obtained for the undigested protein. The
pattern of reagent incorporation among the three fragments
was markedly different under each experimental condition. In
the presence of Ca2, the level of incorporation to fragment N,
M, orCwas similar. In the presence ofCaM, fragmentsC andM
showed a lower level of [125I]TID-PC/16 incorporation than
fragment N. In the presence of PA [125I]TID-PC/16 incorpora-
tion to fragments N and M was lower than that measured for
fragment C. Finally, in the presence of both CaM and PA, the
pattern was similar to that obtained with CaM alone (Fig. 4D).
Incorporation of [125I]TID-PC/16 to fragment C was lower
than that to fragment M, which, in turn, was lower than that
obtained for fragment N. These results show that, besides
affecting the overall exposure of the transmembrane region, the
presence of Ca2, CaM, or PA leads to a specific rearrangement
of hydrophobic domains in PMCA.
Differential Exposure of SERCA Hydrophobic Domains,
Accessible Surface Area—Our next goal was to assess whether
this finding was comparable with the transmembrane domain
conformational changes described for other P-ATPases. As a
model, we chose the Ca2 pump of sarcoplasmic reticulum
(SERCA) because crystallographic structures of this protein in
different conformations are available (23, 24, 44–46). Themost
striking rearrangement in protein structure occurs when the
enzyme binds Ca2, i.e. between E2 (2EAR) and E1 (1SU4). The
extent of interaction with membrane lipids under each condi-
tion was quantified by calculating the ASA as described previ-
FIGURE 4. Relative specific incorporation to N, M, and C fragments
resulting from PMCA proteolysis. Purified PMCA was photolabeled in
the presence of 100 M Ca2 (A), 100 M Ca2 and 200 nM CaM (B), 100 M
Ca2 and 60 M PA (C), or 100 M Ca2 200 nM CaM and 60 M PA (D). The
samples were then digested with V8 protease as described under “Exper-
imental Procedures.” Values were calculated relative to the specific incor-
poration of each fragment in the presence of 1 mM EGTA (E2), which was
taken as 100%. Data shown are mean  S.E. of three to five independent
experiments.
SCHEME 1. Schematic representation of PMCA digestion with V8 protease. The arrows show the residues where the cleavage occurs. The gray boxes
represent the sites of interaction with acidic phospholipids and calmodulin, respectively. N, M, and C correspond to the three resulting fragments, each of
which contains one of three hydrophobic domains (DH). Left, SDS-PAGE representative of the resulting 55-, 40-, and 38-kDa fragments after proteolysiswith V8
protease in the presence of SDS.Mr of proteins used as standards are indicated on the right.
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ously (25). To perform a direct comparison with the results
obtained for PMCA, the transmembrane region of SERCA was
divided into three hydrophobic domains, similar to those
obtained after V8 digestion of PMCA. ASA was calculated for
these domains, and the value obtained for each of them in the
absence of calcium was set as 100%. After binding of calcium,
the conformation in which SERCA is completely activated,
ASA of the three hydrophobic domains decreases. However,
the pattern of differential exposure to phospholipids of each
domain is different from that obtained for activated PMCA, i.e.
in the presence of CaM or PA or both CaM and PA (Table 1).
This result points out a clear difference between the two pumps
and further points at specific mechanisms of activation in
PMCA of both CaM and PA.
Differences between Effect of Acidic Phospholipids and CaM
in Cytoplasmic Domains—The ATP binding site is located in
the cytoplasmic domain between transmembrane segments 4
and 5, which are included in the central and C-terminal hydro-
phobic domains, respectively. The exposure to phospholipids
of these two hydrophobic domains was shown to decrease in
the presence of CaM. Therefore, we wanted to explore a possi-
ble correlation between this transmembrane rearrangement
and a conformational change in the corresponding cytoplasmic
region. To this end, we measured RET between EITC-labeled
PMCA reconstituted in mixed micelles containing C12E10-PC
and RhoPE in different media (Fig. 5A). The Lys residue that
becomes labeled in PMCA is located at the ATP-binding site
(30) of PMCA. Thus, changes in the efficiency of the energy
transfer (see “Experimental Procedures”) indicate whether the
cytoplasmic domain containing the ATP binding site gets
closer to or further away from themembrane.When comparing
with control medium (in the presence of EGTA), Ca2-con-
taining medium increased the efficiency of the energy transfer
by 20%. Addition of CaM to the Ca2-containing medium
decreased the efficiency of RET to about the same value as in
the EGTA-containing medium. These results suggest that in
the conformation E1I (obtained with Ca2 alone) the cytoplas-
mic domain containing the ATP binding site is closer to the
membrane. Addition of CaM renders a conformation in which
this domain is located further away from the membrane. We
thenmeasured the efficiency of energy transfer between EITC-
PMCA and RhoPE with increasing amounts of PC, PE, or PA
(Fig. 5B). As expected, increasing the amount of lipids
decreased the fluorescence because RhoPE was diluted. To
quantify the effect of each phospholipid, Equation 3 was fitted
to the experimental data.
Y 
A  KFL
KFL 	FL

(Eq. 3)
KFL represents the phospholipid concentration needed to
reduce by half the RET efficiency. The best fit value parameter
obtained for KFL (76.3 8.3 M, 84.4 9.1 M, and 79.7 9.3
M for phosphatidylcholine, phosphatidylethanol-amine, and
phosphatidic acid, respectively) was indistinguishable for the
different phospholipids, i.e. the decrease in RET efficiency was
the same regardless of the nature of the phospholipid added.
This indicates that during the activation by acidic lipids, the
cytoplasmic domain containing the ATP binding site does not
move significantly farther away from themembrane in contrast
to the results obtained with the enzyme activated by CaM.
DISCUSSION
By using [125I]TID-PC/16, we were previously able to assess
two different transmembrane conformations within PMCA:
one in which the protein displaysmaximum lipid exposure cor-
responding to an autoinhibited state of the enzyme (presence of
Ca2) and another in which protein-lipid interactions are
markedly decreased corresponding to an activated state (pres-
ence of Ca2 and CaM) (13). Using the same experimental
approach, we were also able to measure equilibrium constants
for different ligands through the change of transmembrane
conformations in PMCA (41). We demonstrated that the
apparent affinity constant for Ca2 (KCa2) is not affected by the
presence of either CaM or PA, two of the most relevant modu-
lators of enzyme activity. These results highlight the conven-
ience of directly exploring the effects of different ligands on
PMCA transmembrane region as these are not necessarily
reflected in the rate of ATP turnover; i.e. in steady state condi-
tions, both CaM and PA have been extensively shown to have a
considerable effect on KCa2 (7, 47, 48).
The effect of CaM and PA proved to be additive as assessed
by Ca2-ATPase activity, suggesting that they act through
independent mechanisms. In these experiments, neither CaM
FIGURE5.Efficiencyofenergy transfer (E) betweenEITC-PMCAandRhoPE
underdifferentconditions.A, purifiedEITC-PMCAwasreconstituted inC12E10-
PC-RhoPE mixed micelles (120 M-60 M-0.2 M), and the emission of the
donor was measured in presence of 1 mM EGTA (EGTA), 100 M Ca2 (Ca2),
100MCa2 and200nMCaM (CaM), or purified EITC-PMCAwas reconstituted
in C12E10-PA-RhoPE (120 M-60 M- 0.2 M) (PA). E was calculated as
described under “Experimental Procedures.” The value obtained for E in pres-
ence of EGTA was taken as 100%. B, purified EITC-PMCAwas reconstituted in
C12E10-RhoPEmixedmicelles, and the emission of the donorwasmeasured in
presence of increasing concentrations of PA, PE, or PC. The value obtained for
E in the absence of PC, PE, or PA was taken as 100%. Values reported are
mean S.E. of five and three independent experiments, respectively.
TABLE 1
Relative specific incorporation of 	125I
TID-PC/16 to N, M, and C frag-
ments and PMCA and accessible surface area of the equivalent hydro-
phobic domains in SERCA
The specific incorporation in presence of EGTA (E2 PMCA) and ASA obtained for
E2 SERCA (Protein Data Bank code 2EAR) were taken as 100%.
PMCA SERCA
Enzyme Ca2 CaM PA CaM and PA Ca2
N 126.7 5.5 97.1 4.6 73.7 3.8 104.2 1.0 79.8
M 121.7 2.7 67.8 1.9 83.0 1.5 69.4 8.1 72.8
C 125.3 6.0 79.0 1.9 97.4 1.7 76.5 1.5 87.6
Transmembrane
domain
160.3 1.5 75.0 1.1 91.4 1.3 76.4 2.3 81.7
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nor PA affected the apparent affinity constant of the other
ligand, pointing to nonoverlapping binding sites. Therefore,
although CaM and PA could be expected to share a common
structural effect because they both ultimately perturb a region
connecting transmembrane segmentM3, these ligands are able
to act through unrelated pathways. This does not discard the
presence of a second low affinity binding site shared by both
ligands that has no effect on ATP turnover but is revealed in
binding experiments using synthetic peptides (7, 8).
When interpreting the results of [125I]TID-PC/16 incorpora-
tion experiments, it is important to emphasize that thismethod
probes the overall exposure of membrane segments to phos-
pholipids but not the specific site(s) for acidic phospholipids
in PMCA.The overall exposure to surrounding lipids is less in the
presence of CaM than in the presence of PA and much less in
the presence of either CaM or PA than in the presence of Ca2
alone. The level of compaction elicited by CaM on the trans-
membrane region appears to bemaximumas, in the presence of
this ligand, no changes were observed in the level of [125I]TID-
PC/16 incorporation upon addition of PA. By measuring
changes in the level of [125I]TID-PC/16 incorporation we cal-
culated the value for PA apparent affinity constant, which is in
excellent agreement with that calculated from ATPase mea-
surements. This suggests that the effect of PA on transmem-
brane rearrangement goes in parallel with its effect on the rate
of ATP turnover. In the presence of CaM, this ligand com-
pletely masks any effect that PA exerts on the level of compac-
tion in the transmembrane region, i.e. no further changes are
observed in [125I]TID-PC/16 incorporation within the whole
range of PA concentrations assayed. Similarly, the calculated
apparent affinity constant for CaM through specific incorpora-
tion analysis is in good agreement with that calculated by
Liyanaje et al. (42) and through ATPase activity measurements
(1, 36, 37, 49). This suggests that CaM effect on PMCA trans-
membrane structure is related directly to its effect on ATPase
activity. Furthermore, the fact that the apparent affinity con-
stant for this ligand remains unchanged in the presence of PA
points to an independent effect of CaM on transmembrane
rearrangements, which is also exposed in ATPase activity.
By enzymatically digesting photolabeled PMCA, we were
able to dissect the domains within the transmembrane region
that become specifically exposed to surrounding lipids. Cal-
cium appears to elicit a general expansion of the transmem-
brane region in which every domain is more exposed to mem-
brane lipids. In the presence of CaM or PA, a striking decrease
in [125I]TID-PC/16 incorporation to any of the hydrophobic
domains is observed, which is, on average, comparable with
that observed for the undigested protein under each condition.
However, the pattern of reagent incorporation between the dif-
ferent domains displays interesting variations. In the presence
of CaM, the central domain included in fragment M becomes
less exposed to phospholipids than the C-terminal domain
included in fragment C and much less than the N-terminal
domain included in fragmentN. Activation by CaM is due to its
binding to an autoinhibitory domain located at the C terminus
of PMCA. CaM binding dissociates this C-terminal domain
interaction with two pump domains, with one located just
upstream transmembrane segment M3 and another one
located downstream transmembrane segment M4 of PMCA
relieving the autoinhibition. It is therefore not surprising that
the most affected hydrophobic domains are those that include
transmembrane segments directly connected with cytoplasmic
targets of CaM binding, i.e. domainM, which includes segment
M3 andM4, and domain C, which includes the transmembrane
segment directly connected to the C terminus autoinhibitory
domain. The observed pattern is remarkably different in the
presence of PA. Under this condition, it is the N-terminal
domain (fragment N) that becomes less exposed. The central
domain (fragment M) presents an intermediate exposure,
whereas the C-terminal domain shows the highest level of
[125I]TID-PC/16 incorporation. PA binding sites have been
identified within the cytoplasmic loop that connects trans-
membrane segments M2 and M3 (AL region) and in the C-ter-
minal region of PMCA (7, 8). Mutagenesis experiments suggest
that the function of this AL region is independent of the C-ter-
minal autoinhibitory region (10). In our experiments, the most
affected hydrophobic domains are those that include the trans-
membrane segments directly connected with the AL region, i.e.
domain N, which includes M2, and domain M, which includes
M3. In the simplest scenario, these changes would be occurring
as a result of PA binding to AL region, although PA binding to
the C-terminal region cannot be ruled out. Nevertheless, the
results obtained using our experimental design explicitly high-
light the difference in the transmembrane arrangement result-
ing from PA activation as compared with that resulting from
CaM activation.
The difference in the pattern of [125I]TID-PC/16 incorpora-
tion between the two activating conditions further supports the
conclusion that CaM and PA exert their effects through differ-
ent pathways. In the presence of both activators, the pattern of
[125I]TID-PC/16 incorporation is remarkably similar to that
obtained in the presence of CaM alone. This result further sup-
ports the conclusion that the transmembrane arrangement
elicited by CaM is not modified by the presence of PA. The
transmembrane region compaction after activation is also
observed in the SERCA. In this P-typeATPase, ASA calculation
shows that the activation of the enzyme involves the compac-
tion of the three hydrophobic domains analyzed in this work.
However, the level of compaction of each domain is different
from that elicited by CaM or PA in PMCA. This difference
regarding the transmembrane structure upon activation is
directly related to the major functional difference between
these two P-ATPases, which lies precisely in the presence of the
C terminus and the phospholipid binding domains that regu-
late Ca2-ATPase activity.
Regarding cytoplasmic rearrangements, both CaM and PA
were shown to increase the distance between N- and C-termi-
nal regions (12). CaM increased the distance between the ATP
binding site and the phospholipidicmembrane as shown by our
RET experiments, whereas this distance remained unchanged
in the presence of PA. The ATP binding site is located between
transmembrane segments 4 and 5 included in the central
domain and the C-terminal hydrophobic domains, respec-
tively. Thesewere the hydrophobic domains that showedmajor
changes in the presence of CaM in our [125I]TID-PC/16 incor-
poration experiments. Our data agree very well with the idea
PMCADifferential Exposure of Hydrophobic Domains
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that in the E2 conformation the inhibitory region is tightly
bound to the catalytic core so that it forms a compact structure,
whereas the transmembrane domain adopts a more relaxed
conformation.On the other hand, in the E1A conformation, the
transmembrane domain adopts amore compact conformation.
Within this general architecture elicited by both activators, we
found important differences between the structural effect of
CaM or PA, which were observed both at the transmembrane
and cytoplasmatic domains. Taken together, our results indi-
cate that regulation of PMCA activity by PA or CaM is achieved
by different mechanisms.
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